1. Home
  2. MIND vs TCRX Comparison

MIND vs TCRX Comparison

Compare MIND & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

HOLD

Current Price

$4.74

Market Cap

83.4M

Sector

Industrials

ML Signal

HOLD

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

HOLD

Current Price

$1.08

Market Cap

75.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIND
TCRX
Founded
1987
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.4M
75.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MIND
TCRX
Price
$4.74
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.00
AVG Volume (30 Days)
116.7K
635.0K
Earning Date
04-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
12.28
EPS
N/A
N/A
Revenue
N/A
$10,325,000.00
Revenue This Year
$23.31
N/A
Revenue Next Year
$1.01
$19.81
P/E Ratio
$22.27
N/A
Revenue Growth
N/A
266.65
52 Week Low
$4.66
$0.83
52 Week High
$14.50
$2.57

Technical Indicators

Market Signals
Indicator
MIND
TCRX
Relative Strength Index (RSI) 31.71 57.66
Support Level N/A $0.89
Resistance Level $6.89 $1.16
Average True Range (ATR) 0.27 0.09
MACD -0.00 0.03
Stochastic Oscillator 10.19 81.35

Price Performance

Historical Comparison
MIND
TCRX

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Share on Social Networks: